Suppressive ability of CD4+CD25+ Foxp3+ Treg cells isolated from PBMCs of CeD patients and controls has been investigated using autologous CD4+CD25- T responders (Tresp) cells, with conflicting results. This evidence concerns the gene CD4 and cranioectodermal dysplasia.